Under the background of new policies, How to truly achieve mutual recognition of inspection results?
How to truly achieve mutual recognition of inspection results?
Senxu Medical provides solutions for you
2021 year 7 moon 16 day, Issued by the National Health Commission "Notice on Accelerating the Mutual Recognition of Inspection and Testing Results" (hereinafter referred to as "notice" ) . "notice" Intended to promote mutual recognition and sharing of inspection and testing results, Improve the efficiency of medical resource utilization, Reduce the burden of medical treatment on the people.
The premise of mutual recognition of inspection results is to ensure the accuracy of laboratory inspection results and the comparability of laboratory inspection results. Strict quality control is the prerequisite and guarantee for mutual recognition of results. Quality control is an important means for clinical laboratories to ensure accurate results, The monitoring measures mainly include indoor quality control and inter room quality evaluation, Indoor quality control is an important method for monitoring the precision and accuracy performance changes of detection systems, Indoor quality assessment activities are used to evaluate accuracy, The results can reflect the technical level of the participating laboratories during a certain period, Testing system and quality management status. The comparability of test results for the same item in different testing systems within a laboratory is an important technical indicator of medical laboratory accreditation standards, The consistency of laboratory test results is an important way to achieve accuracy traceability and comparability of test results.
The purpose of mutual recognition of test results among medical institutions within the region:
Recognize the inspection results issued by medical institutions that have been included in the mutual recognition system for inspection and testing results, No more repeated checks will be conducted.
The means and key points for medical institutions in the region to achieve mutual recognition of test results:
Provincial health administrative departments suggest that medical institutions at all levels adoptInformation technology meansPromote mutual recognition of inspection results, Information sharing situation andreal-time monitoring. For high-value high frequency, Real time monitoring of inspection items highlighted by public feedback, Gradually realizing theAutomatic detection of unreasonable inspections, auto-reminder, Automatic intervention.
Key and bottleneck issues in achieving mutual recognition of inspection results through information technology platforms:
The prerequisite for mutual recognition of inspection results is to achieve consistency and accuracy of the results, Not just universal sharing of results, These are all urgent problems that need to be solved at present.
Alpha-ICO Building a comprehensive solution
Alpha-ICO It is a carrier and platform to assist medical consortia and medical institutions in the region in the informationization and intelligent construction of medical laboratory specialties, Suitable for urban medical groups, The construction mode of county-level medical community and regional medical institutions.
Alpha-ICO Including the Regional Inspection Center Laboratory Information Management Cloud Platform and Medical Consortium AI-MA Real time comparison between laboratories on intelligent monitoring cloud platform (medical consortium AI-MA cloud platform) wait, Implement laboratory personnel for different levels of medical institutions, machine, material, Environmental Integration, Visual intelligent monitoring and real-time management of the entire process of quality risk and mutual recognition of results.
AI-MA Introduction to Patient Data Intelligent Monitoring Platform
International Federation of Clinical Chemistry (IFCC) The Federation of Laboratory Medicine 2019 The guidance document published in the year proposes real-time quality control based on patients ( patient based realtime quality control , PBRTQC) It is a method of using patient test results in real-time, Quality control methods for analyzing performance in continuous monitoring and testing processes, Compared with traditional quality control methods, it has lower cost, No matrix effect, Advantages of continuous real-time performance monitoring and sensitivity to pre analysis errors, including BULL law, AON law, MA law, The median method and EWMA Various computational programs such as law.
Patient data real-time quality control intelligent monitoring platform developed by Senxu Medical (AI-MA) It is a real-time continuous monitoring of the performance and quality risks of the entire analysis process using patient results, recognize, Early Warning and Quality Management PBRTQC Professional intelligent management software tool. Development based on artificial intelligence and medical big data analysis technology, Modeling based on international quality control management theory and authoritative statistical methods of national industry standards, conform to IFCC concerning PBRTQC The functional characteristics of professional software tools, Program establishment, Technical requirements for implementation and operation, isPBRTQC Professional software intelligent management tool.
medical consortium AI-MA cloud platform
based on AI+5G Real time quality control of patient data in medical consortia, inter laboratory comparison, and intelligent monitoring cloud platform (medical consortium AI-MA cloud platform) Real time dynamic capability, Continuous monitoring of the stability and potential quality risks of the analytical performance of each laboratory testing system in the medical consortium, At the same time, the median method can be flexibly selected, EWMA Law, etc, Adopting patient big data, Fresh specimens, Compare quality control products between laboratories, Realize consistency of results between medical consortium laboratories, Provide a basis for mutual recognition of test results between medical consortium experiments.

At the same time, it can be flexibly based on quality control products, Fresh specimens and patient big data for inter laboratory comparison, Statistical analysis and intelligent warning, Realize consistency of results, Promote the intelligent construction of medical consortia, homogenization, High quality development and mutual recognition of results, Provide benefits to patients and the general public.

01
Intelligent monitoring of quality management in laboratories of medical institutions at all levels within the region
Real time dynamics through indoor quality control products and patient big data, Continuously monitor the stability and potential quality risks of the analysis performance of each laboratory testing system in medical institutions within the monitoring area.
02
Laboratories of medical institutions at all levels within the regionMutual recognition of results
andIntelligent monitoring solution
Indoor quality control products can be used, Fresh specimens and patient big data, Flexible selectionMedian method for inter laboratory comparison based on patient data EWMA Conduct inter laboratory result consistency analysis using the method, Intelligent warning for incomparable items with precision and bias exceeding the allowable range of mutual recognition of results.
03
internationalization, standardization, standardization
PBRTQC Professional software tools
AI-MA conform to IFCC Related to the Federation of Laboratory Medicine PBRTQC Functional characteristics and technical requirements of professional software tools, can provide PBRTQC data collection, Parameter Settings, performance verification, parameter optimization, choice, Quality Control Efficiency Evaluation, Implement and run the overall solution in real-time.
04
Comprehensive quality control strategy (TQC) Intelligent monitoring platform
AI-MA of PBRTQC Law and quality control products QC Joint application of law, Intelligent monitoring and analysis of potential quality risks throughout the entire process and time period, Ensure the accuracy of the results, Reduce medical risks.

05
medical consortium AI-MA Core innovative features of cloud platform

06
AI-MA Cloud platform in laboratories of medical institutions at all levels of the medical consortium
Application scenarios for quality risk control

07
AI-MA Cloud platform between medical institutions' laboratories at all levels of the medical consortium
Application scenarios for quality risk control

08
AI-MA Application of cloud platform in mutual recognition of results

09
Comprehensive quality control strategy (TQC) Intelligent monitoring platform






